Starpharma after 22 years, page-4

Lets hit reset here on timelines and just talk about current activities and what deadlines are in front of us.

DEP Trials - End of 2022

VIRALEZE - No real deadlines have been stated by company other than the throw away line of deals/lisenses are being negotitated and we all know what that means in terms of timelines......

VIVAGEL - FDA debacle ongoing with no end in sight.

That about wraps it up i think.

So in summary we are pretty much reliant on DEP getting this company to the highs we all think it should hit.

Over to you now Jackie and SPL, you have until the end of the year to deliver results and the licences that you have promised us once proof of concept has been proven.

I hope that if the results are not delivered by AGM then there will be some very testy shareholders, not just the retail ones either. 2022 MUST be the year that DEP potential is realised or this little aussie biotech will fade into obscurity I fear.